Core Insights - The company is initiating the clinical phase of its collaboration with Orano Med, focusing on pioneering radiotherapy with the introduction of the first Radio-DARPin human image [2][3] Group 1: Company Overview - Patrick Amstutz, the CEO, emphasized the significance of the collaboration agreement signed approximately two years ago with Orano Med [2] - The webcast aims to discuss the lead program and upcoming studies related to the Radio-DARPin technology [2] Group 2: Key Personnel - The presentation includes contributions from Dani Steiner, Head of Radio Strategy, Philippe Legenne, Chief Medic, and Michael Stumpp, the program lead, who will handle the Q&A session [3]